20 articles
A Cochrane meta-analysis of 17 RCTs finds blue light TURBT reduces bladder cancer recurrence and progression, especially in intermediate- and high-risk patients.
New technique uses cerebrospinal fluid to decode methylation signatures in children's brain tumors, potentially improving diagnosis.
Engineered magnetotactic bacteria delivered orally penetrate colorectal tumors, trigger immune attack, and reshape gut microbial metabolism in mice.
Cambridge scientists engineer a nanoprobe that detects therapy-induced senescence non-invasively through a simple urine colorimetric test.
Specific bacterial metabolic pathways in the gut determine whether cancer immunotherapy works by controlling immune responses.
Scientists develop bacteria that colonize tumors and secrete proteins to highlight cancer tissue with 15x better contrast than current methods.
Inhibiting the mitophagy kinase PINK1 amplifies mitochondrial ROS, activating a BAX-caspase-GSDME cascade that destroys neuroblastoma cells via pyroptosis.
Phase I trial of Temab-A reports 15.6% response rate and 74.6% disease control in heavily pretreated metastatic colorectal cancer patients.
Researchers analyzed 1,294 blood samples to create a comprehensive cancer detection method using cell-free DNA patterns.
Widely-used anesthetic triggers immune system to attack tumors and enhances checkpoint inhibitor therapy effectiveness.
Engineered green tea compound nanoparticles activate cellular powerhouses to suppress tumor growth and improve immune response against melanoma.
New ColonTrack model identifies early-stage colorectal cancer with 94% accuracy using three proteins from blood-based extracellular vesicles.
New blood test identifies early-stage breast and lung cancers by measuring epigenetic chaos in cell-free DNA fragments.
Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.
New liquid biopsy combining DNA methylation and protein markers shows promise for early multi-cancer detection across nine major cancer types.
Removing dietary copper starves leukemia cells of nucleotide building blocks, boosting methotrexate efficacy against hard-to-treat CNS disease.
New study shows how analyzing fluid from lungs can detect cancer mutations and guide personalized treatment decisions.
Scientists develop brain-penetrating drug that makes glioblastoma cells vulnerable to targeted elimination therapy.
A gut metabolite produced after chemo reprograms bone marrow immune cells, creating a lasting shield against colorectal cancer liver metastasis.
New liquid biopsy technique identifies molecular residual disease in colorectal cancer patients to guide personalized treatment decisions.
